Developer docs
API playgroundTry for free, no card

Search company profiles

Sequoia Pharmaceuticals

Full company profile

uuid002sgho

Namestring
Sequoia Pharmaceuticals
Websiteurl
sequoia.pl
Company typeenum
Private
Founded yearint
2008
Short descriptiontext

Sequoia Pharmaceuticals is a privately held Warsaw-based pharmaceutical company founded in 2008 that develops and manages pharmaceutical products, operating with a 101-250 employee headcount. Specific product, customer, and revenue disclosures are not available in the source data.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWarsaw, Poland
HQ citystring
Warsaw
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
pharmaceutical products, drug development, pharmaceutical management, medicine manufacturing, pharmaceutical distribution
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Manufacturing
No data
Cost components4 values
Personnel, Supply Chain, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Sequoia Pharmaceuticals develops and manages pharmaceutical products. The company operates as a privately held pharmaceutical firm headquartered in Warsaw, Poland, founded in 2008, with a workforce of 101–250 employees. Beyond this general description, no specific product lines, therapeutic areas, dosage forms, or commercialized drugs are documented in the available sources.

Differentiator
Functional benefit
Problem solved
Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sequoia Project Pharmacy Interoperability Workgroup collaborates with NCPDP on developing standards and implementation guides supporting care coordination and pharmacy interoperability. This workgroup is part of NCPDP's collaborative initiatives with external organizations to advance pharmacy interoperability standards heading into 2025.

Peers10 records
TypeDirect peer
Description

Slovenian generic pharmaceutical manufacturer with strong CEE and CIS market presence. Comparable to Sequoia Pharmaceuticals as an established Central European pharma developer with a focus on generic and specialty pharmaceutical products.

TypeDirect peer
Description

Poland's largest pharmaceutical manufacturer and one of the leading generic drug producers in Central Europe. Directly comparable to Sequoia Pharmaceuticals as a Poland-based pharma operator producing and managing medicinal products across multiple therapeutic categories.

TypeRegional player
Description

Polish pharmaceutical company focused on developing and manufacturing generic drugs and specialty pharma products. Comparable to Sequoia Pharmaceuticals as a Poland-based pharma operator, with similar therapeutic and regional focus areas.

TypeDirect peer
Description

Hungarian pharmaceutical manufacturer producing generic, branded, and OTC medicines with significant CEE distribution. Comparable to Sequoia Pharmaceuticals as a Central European pharma developer with established product portfolio and regional reach.

TypeDirect peer
Description

Polish pharmaceutical and biotech company developing, manufacturing, and marketing both branded and generic drugs. Directly comparable to Sequoia Pharmaceuticals as a Warsaw-based pharma business with full development-to-commercialization capabilities.

TypeBroad incumbent
Description

Global leader in generic and biosimilar medicines spun off from Novartis. Comparable to Sequoia Pharmaceuticals as a pharmaceutical products developer/manufacturer, though operating at significantly greater scale and geographic scope.

TypeBroad incumbent
Description

Global pharmaceutical company formed from the combination of Mylan and Upjohn, focused on generics, branded, and biosimilar medicines. Comparable as a broad pharma operator managing large portfolios of established pharmaceutical products across many markets.

TypeDirect peer
Description

Hungarian-headquartered pharmaceutical company with a broad portfolio in generic and specialty drugs, women's health, and biosimilars. Comparable as a Central European pharma manufacturer and brand owner with multi-decade operating history.

TypeBroad incumbent
Description

World's largest generic pharmaceutical manufacturer with operations across all major geographies. Broadly comparable to Sequoia Pharmaceuticals as a generic and specialty pharma operator, though vastly larger and globally diversified.

TypeDirect peer
Description

A major European generics pharmaceutical company headquartered in Prague with significant manufacturing presence across Central and Eastern Europe. Comparable as a CEE-based pharmaceutical developer/manager operating at scale across generics and specialty pharma.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sequoia Pharmaceuticals

Pharmaceutical Manufacturingsequoia.pl

Sequoia Pharmaceuticals is a privately held Warsaw-based pharmaceutical company founded in 2008 that develops and manages pharmaceutical products, operating with a 101-250 employee headcount. Specific product, customer, and revenue disclosures are not available in the source data.

Sequoia Pharmaceuticals firmographics

Firmographics
Name
Sequoia Pharmaceuticals
Website
https://sequoia.pl
Company type
Private
Founded year
2008
Headcount range
101–250 employees
Short description
Sequoia Pharmaceuticals is a privately held Warsaw-based pharmaceutical company founded in 2008 that develops and manages pharmaceutical products, operating with a 101-250 employee headcount. Specific product, customer, and revenue disclosures are not available in the source data.
Ownership category
akta.pro rank

Where Sequoia Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Warsaw
HQ country
Poland
HQ region
Europe

Markets served

Sequoia Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D

Sequoia Pharmaceuticals product offering

Product offering

Core offering

Sequoia Pharmaceuticals develops and manages pharmaceutical products. The company operates as a privately held pharmaceutical firm headquartered in Warsaw, Poland, founded in 2008, with a workforce of 101–250 employees. Beyond this general description, no specific product lines, therapeutic areas, dosage forms, or commercialized drugs are documented in the available sources.

Differentiator

Problem solved

Functional benefit

Companies that use Sequoia Pharmaceuticals

Customer profile

Ideal customer profiles1 record

Sequoia Pharmaceuticals technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sequoia Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sequoia Project Pharmacy Interoperability WorkgroupcoreStrategic or Co-development PartnerSequoia Project Pharmacy Interoperability Workgroup collaborates with NCPDP on developing standards and implementation guides supporting care coordination and pharmacy interoperability. This workgroup is part of NCPDP's collaborative initiatives with external organizations to advance pharmacy interoperability standards heading into 2025.

Sequoia Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Krka: Slovenian generic pharmaceutical manufacturer with strong CEE and CIS market presence. Comparable to Sequoia Pharmaceuticals as an established Central European pharma developer with a focus on generic and specialty pharmaceutical products.
  • Polpharma: Poland's largest pharmaceutical manufacturer and one of the leading generic drug producers in Central Europe. Directly comparable to Sequoia Pharmaceuticals as a Poland-based pharma operator producing and managing medicinal products across multiple therapeutic categories.
  • Egis Pharmaceuticals: Hungarian pharmaceutical manufacturer producing generic, branded, and OTC medicines with significant CEE distribution. Comparable to Sequoia Pharmaceuticals as a Central European pharma developer with established product portfolio and regional reach.
  • Adamed Pharma: Polish pharmaceutical and biotech company developing, manufacturing, and marketing both branded and generic drugs. Directly comparable to Sequoia Pharmaceuticals as a Warsaw-based pharma business with full development-to-commercialization capabilities.
  • Gedeon Richter: Hungarian-headquartered pharmaceutical company with a broad portfolio in generic and specialty drugs, women's health, and biosimilars. Comparable as a Central European pharma manufacturer and brand owner with multi-decade operating history.
  • Zentiva: A major European generics pharmaceutical company headquartered in Prague with significant manufacturing presence across Central and Eastern Europe. Comparable as a CEE-based pharmaceutical developer/manager operating at scale across generics and specialty pharma.

Regional players

  • Celon Pharma: Polish pharmaceutical company focused on developing and manufacturing generic drugs and specialty pharma products. Comparable to Sequoia Pharmaceuticals as a Poland-based pharma operator, with similar therapeutic and regional focus areas.

Broad incumbents

  • Sandoz: Global leader in generic and biosimilar medicines spun off from Novartis. Comparable to Sequoia Pharmaceuticals as a pharmaceutical products developer/manufacturer, though operating at significantly greater scale and geographic scope.
  • Viatris: Global pharmaceutical company formed from the combination of Mylan and Upjohn, focused on generics, branded, and biosimilar medicines. Comparable as a broad pharma operator managing large portfolios of established pharmaceutical products across many markets.
  • Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with operations across all major geographies. Broadly comparable to Sequoia Pharmaceuticals as a generic and specialty pharma operator, though vastly larger and globally diversified.

Market position

Customer concentration

Sequoia Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sequoia Pharmaceuticals leadership team

Management profile

Number of profiles

Sequoia Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sequoia Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sequoia Pharmaceuticals

What does Sequoia Pharmaceuticals do?

Sequoia Pharmaceuticals develops and manages pharmaceutical products. The company operates as a privately held pharmaceutical firm headquartered in Warsaw, Poland, founded in 2008, with a workforce of 101–250 employees. Beyond this general description, no specific product lines, therapeutic areas, dosage forms, or commercialized drugs are documented in the available sources.

When was Sequoia Pharmaceuticals founded?

Sequoia Pharmaceuticals was founded in 2008. It employs 101 to 250 people.

Where is Sequoia Pharmaceuticals based?

Sequoia Pharmaceuticals is headquartered in Warsaw, Poland, in the Europe region.

Who are Sequoia Pharmaceuticals's main competitors?

Direct peers on record are Krka, Polpharma, Egis Pharmaceuticals, Adamed Pharma, Gedeon Richter and Zentiva. Celon Pharma is listed as a regional player. Broad incumbents are Sandoz, Viatris and Teva Pharmaceutical Industries.

Does Sequoia Pharmaceuticals have an API?

No public API is recorded for Sequoia Pharmaceuticals.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales